Neurocrine [NBIX] vs S&P 500 [^GSPC] Detailed Stock Comparison
Index Comparison
You are comparing market indices. Financial metrics such as P/E ratios, dividend yields, and financial statements are not available for indices as they represent market benchmarks rather than individual companies.
Available data includes: price performance, historical charts, and basic market statistics.
Neurocrine Biosciences Inc. vs S&P 500 Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Neurocrine Biosciences Inc. | 6.63% | -0.56% | 15.51% | 16.98% | 1.56% | 10.14% |
| S&P 500 | -0.74% | 1.63% | -4.34% | -4.02% | -1.98% | -4.02% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Neurocrine Biosciences Inc. | 28.68% | 71.47% | 67.71% | 219.67% | 1,955.84% | 680.19% |
| S&P 500 | 29.73% | 60.36% | 59.43% | 221.48% | 395.62% | 408.12% |